Xpect Cold Relief
- Product NDC
- 42961-112
- Requested package NDC
- 42961-112-12
- 11-digit product format
- 429610112
- Labeler code
- 42961
- Product ID
- 42961-112_59bbb82a-0247-417c-b0ed-991646373be8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen Guaifenesein Phenylephrine HCl
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cintas Corporation
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-03-29
- Substance
- GUAIFENESIN; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 200; 325; 5 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 42961-112 | 42961-112-12 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42961-112 | 42961-112-12 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Xpect Cold Relief
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 200 mg/1 |
| ACETAMINOPHEN | 325 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
| 362O9ITL9D | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1243679 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 02391d55-32b2-4083-9315-98e9b3650c55 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42961-112-10 | Xpect Cold Relief | 2 in 1 PACKET | TABLET | 2 | 10 | |
| 42961-112-11 | Xpect Cold Relief | 80 in 1 BOX | TABLET | 80 | 10 | |
| 42961-112-12 | Xpect Cold Relief | 200 in 1 BOX | TABLET | 200 | 10 | |
| 42961-112-13 | Xpect Cold Relief | 25 in 1 BAG | TABLET | 25 | 10 | |
| 42961-112-14 | Xpect Cold Relief | 40 in 1 BOX | TABLET | 40 | 10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2026-11-02 | Warnings | M013 |
| acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | dc430980-5994-4e61-ad3d-181f5fdc769d | 2026-11-02 | Warnings | M013 |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | f1157dbc-d86c-4554-954c-60a74674ff6b | 2026-11-02 | Warnings | M013 |
| equate pain reliever | ACETAMINOPHEN | WALMART INC. | 59d01f72-4575-48e2-b914-b6a6456ca7d2 | 2026-11-02 | Warnings | M013 |
| equate aspirin chewable | ASPIRIN | Wal-Mart Stores Inc | 9147c0ce-fcdb-457c-b9f5-e4edd66e91d0 | 2026-11-01 | Warnings | M013 |
| Muscle and Joint Pain Reliever Cream Ultra Strength | MUSCLE AND JOINT CREAM | Savvy Care & Cosmetics Pvt. Ltd. | 5f215bd6-e7e9-59e3-e063-6394a90a169a | 2026-10-31 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 9cdfa6fb-4bc5-4a54-93fc-edd84bf80ef3 | 2026-10-30 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | LEADER/ Cardinal Health 110, Inc. | b3773f02-02a9-33c8-e053-2995a90a2235 | 2026-10-30 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | 6ec12573-03d6-40c1-9945-d345b401e062 | 2026-10-30 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Meijer | 181aee35-8fb2-35e4-e063-6394a90a6b3b | 2026-10-29 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN 500MG | Demoulas Super Markets, Inc. | 36dbcb69-40b9-495b-b5a1-60693f06145d | 2026-10-28 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | 06a0fc1f-4cac-4d0f-9349-90a0fb4cc0c8 | 2026-10-28 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | Bi-Mart | 35483db0-d6b8-4b37-8113-1dbe51e42ae5 | 2026-10-28 | Warnings | M013 |
| Pain Relief Rapid Release Gelcaps Extra Strength | ACETAMINOPHEN | Safeway | c830d1ac-c4c5-4eb1-98bb-22707cb6db91 | 2026-10-28 | Warnings | M013 |
| Adult Low Dose Aspirin | ASPIRIN | HYVEE INC | 45ae4509-fb50-66fd-e063-6294a90a2d7b | 2026-10-28 | Warnings | M013 |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 4cc4b39a-39d5-a2bb-e063-6394a90a2e95 | 2026-10-28 | Warnings | M013 |
| Gencare-Aspirin Low Dose Pain reliever (NSAID) | ASPIRIN | Pioneer Life Sciences, LLC | 24d4f46a-c7a5-4e94-804f-1e307d8e8cfc | 2026-10-28 | Warnings | M013 |
| Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | 2d375ec9-a528-4048-a15b-652fa20e74a7 | 2026-10-28 | Warnings | M013 |
| Aspirin Enteric Coated | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | f1ce15a3-9824-4eb5-910a-39078165f385 | 2026-10-28 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | L.N.K. International, Inc. | ec902e52-0f48-4a61-b67d-17e1c1461619 | 2026-10-28 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1243679 | acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | PSN | 02391d55-32b2-4083-9315-98e9b3650c55 | 10 |
| 1243679 | acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SCD | 02391d55-32b2-4083-9315-98e9b3650c55 | 10 |
| 1243679 | APAP 325 MG / GG 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SY | 02391d55-32b2-4083-9315-98e9b3650c55 | 10 |
| 1243679 | APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet | SY | 02391d55-32b2-4083-9315-98e9b3650c55 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 42961-112-12 | 42961011212 | 200 PACKET in 1 BOX (42961-112-12) > 2 TABLET in 1 PACKET (42961-112-10) | 200 packet | 2022-12-30 | 0000-00-00 | No | No | Current |